MPN&MPNr-EuroNet 15th meeting, Ljubljana, Slovenia

The aims of MPN&MPNr-EuroNet’s fifteenth meeting to be held in Ljubljana, Slovenia, on April 21-23 2021 are:

1. to share information on the newest developments in MPNs and related congenital diseases, hereditary erythrocytosis and hereditary thrombocytosis;
2. to exchange and diffuse the latest information and recommendations on the molecular assays developed for diagnosis or research in laboratories working on MPNs and related diseases across Europe. NGS and novel technologies will be special focuses of this meeting;
3. to provide recommendations for therapy of MPN;
4. to discuss and plan for the various tasks and objectives of the three MPN&MPNr-EuroNet working groups (WG);
5. to help and mentor young scientists interested in MPNs and related congenital
   diseases, hereditary erythrocytosis and hereditary thrombocytosis.
   To do so, abstracts will be selected for short talks in the different sessions. Posters will
   be presented during the whole length of the meeting.
   Plenary sessions will cover the newest knowledge in MPNs, hereditary erythrocytosis and thrombocytosis. Each WG will convene under the direction of the WG chairs. New participants are encouraged to become actively involved in specific WG tasks.

Participants to the fifteenth MPN&MPNr-EuroNet meeting will have the opportunity to hear from international experts about the newest developments in the molecular diagnosis of MPNs and related congenital/hereditary diseases. They will have the opportunity to present their own work and original diagnostic assays, and exchange with colleagues and experts on the newest genes and techniques of interest in the field of MPNs, congenital erythrocytosis and hereditary thrombocytosis. By joining one or more of MPN&MPNr-EuroNet working groups, they will be able to contribute actively, productively and durably in innovation, optimization and standardization of the biological diagnosis of MPNs and related congenital diseases in Europe.

molecular diagnosis, myeloproliferative neoplasms, congenital erythrocytosis, hereditary thrombocytosis, standardization, European network

Click on the following link to get more info about MPN&MPNr-EuroNet.

Participants are encouraged to submit an abstract in relation to the diagnosis of MPNs, hereditary erythrocytosis and thrombocytosis, new mutations and gene editing in MPNs, hereditary erythrocytosis and thrombocytosis, the histopathology, pathogenesis and inflammation in MPNs, the JAK/STAT and other signaling pathways and the mechanism of oxygen sensing. NGS and novel technologies will be the special focuses of this meeting.. Early stage researchers and junior biologists and clinicians are especially encouraged to submit abstracts.
Abstracts should be composed as follows:

• Title
• Names of co-authors
• Affiliations
• E-mail address of corresponding author
• Text (maximum 2000 characters, including spaces).

All abstracts will be assembled in an abstract book that will be distributed to participants during the meeting.
The deadline for submission of abstracts is March 2nd, 2021.

In order to submit an abstract, participants should first be registered, then, being logged in, choose Abstract in the menu bar on Registration page.